Originally published by our sister publication Gastroenterology & Endoscopy News
WASHINGTON—Gastroenterologists and hepatologists still are seeing the effects of the COVID-19 pandemic, which has manifested in increased mortality rates for alcohol-associated liver disease and nonalcoholic fatty liver disease among younger people and some ethnic minority groups, as well as a significant, sustained increase in hospital admissions for alcohol-related hepatitis, according to two studies